Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Minerals Corporation Aktie 550275 / AU000000MSC6

30.10.2025 11:49:00

Agnico Eagle launches $130M Avenir unit for critical minerals

Canada’s Agnico Eagle Mines (TSX, NYSE:AEM) has launched a new subsidiary, Avenir Minerals Limited, to manage and advance nearly $80 million in early-stage critical minerals investments. The Toronto-based gold miner will also contribute $50 million in cash to fund the new company and retain a right of first refusal on future investment opportunities, with the option to provide additional capital later.Avenir will evaluate and develop critical mineral opportunities outside Agnico’s core gold and copper operations. Operating as an independent and self-sustaining entity, it will pursue strategic partnerships and government support for critical mineral projects, with a primary focus on Canada.The move follows Agnico’s $180 million investment earlier this week in Perpetua Resources (NASDAQ, TSX: PPTA), a US-based gold and antimony producer developing the $1.3 billion Stibnite project in Idaho. The project, supported by the US government, aims to rebuild domestic supplies of critical minerals.Agnico’s decision to fold its non-core investments into Avenir came alongside record third-quarter results, fuelled by higher gold prices and consistent output across its mines.JPMorgan, Agnico Eagle pour $255M into Perpetua ResourcesThe company reaffirmed its 2025 production and cost guidance. It reported net income of $1.06 billion, or $2.10 a share, for the quarter. Adjusted net income reached a record $1.09 billion, or $2.16 a share. Operating cash flow totalled $1.82 billion, with free cash flow of $1.19 billion.“We delivered another quarter of strong and consistent operational performance, which translated into record financial results as higher gold prices continue to drive expanded margins,” president and CEO Ammar Al-Joundi said in a statement. “We are well on track to meet our full-year production and cost guidance, supported by disciplined cost management and a focus on productivity.”The miner maintained its full-year production forecast of 3.3 million to 3.5 million ounces of gold, with costs expected to trend toward the higher end of its range due to increased royalties. Capital spending for 2025 is projected between $1.75 billion and $1.95 billion, excluding capitalised exploration of $290 million to $310 million.Agnico ended the quarter with a strengthened balance sheet, holding $2.36 billion in cash and reducing long-term debt to $196 million, resulting in a net cash position of $2.16 billion as of September 30. Moody’s upgraded its long-term issuer rating to A3 from Baa1 in August. The company declared a quarterly dividend of $0.40 a share and repurchased just over one million shares for $150 million.BMO Capital Markets analysts described Agnico’s quarter as “solid,” noting production and sales exceeded expectations. “Projects are on track and guidance was reiterated, although unit costs could trend to the high end given gold pricing well above guidance levels,” analyst Matthew Murphy wrote.Key projectsDevelopment work continued across Agnico’s key growth assets, including Canadian Malartic, Detour Lake, Upper Beaver, Hope Bay, and San Nicolas. At Canadian Malartic, shaft sinking and development of East Gouldie levels are advancing toward production in the second half of 2026, while drilling continues to extend mineralisation at depth.The Detour Lake underground ramp advanced 259 metres in the quarter, and construction of the Upper Beaver shaft is set to begin in the fourth quarter. Exploration at Hope Bay returned high-grade intercepts, including 16.9 g/t gold over 4.6 metres and 12.7 g/t gold over 9.3 metres in the Madrid deposit’s Patch 7 zone. At San Nicolas in Mexico, engineering for the feasibility study is expected to be 30% complete by year-end.Agnico Eagle shares were up slightly in pre-market trading in New York, changing hands at $158. The company’s market value stands near $79 billion.Weiter zum vollständigen Artikel bei Mining.com

Analysen zu Minerals Corporation Limited MSCShs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’974.31 19.37 BP9SUU
Short 13’215.46 13.98 BU9S6U
Short 13’724.19 8.85 B19SNU
SMI-Kurs: 12’465.39 10.11.2025 17:30:00
Long 11’962.62 19.84 SNLBQU
Long 11’690.01 13.82 SSTBSU
Long 11’209.46 8.98 SQZB6U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com